TGF beta1 and related-Smads contribute to pulmonary metastasis of hepatocellular carcinoma in mice model
- PMID: 23151305
- PMCID: PMC3503772
- DOI: 10.1186/1756-9966-31-93
TGF beta1 and related-Smads contribute to pulmonary metastasis of hepatocellular carcinoma in mice model
Abstract
Background: Recent studies indicate that Transforming Growth Factor beta (TGF β) correlated with pulmonary metastasis of cancers. However, the correlation between TGF β and pulmonary metastasis of hepatocellular carcinoma (HCC) is till unknown.
Methods: We detected the in vitro and in vivo expression levels of TGF β1/Smads by Real-time PCR and Western blot in MHCC97-H and MHCC97-L cell lines, which are HCC cell lines and have higher and lower pulmonary metastatic potential respectively.
Results: TGF β1 mRNA level in MHCC97-L tumors were higher than that in MHCC97-H tumors, (2.81±1.61 vs. 1.24±0.96, P=0.002), TGF β1 protein level in MHCC97-L tumors were also higher than that in MHCC97-H tumors (1.37±0.95 vs. 0.32±0.22, P<0.001). In addition, the TGF β1 mRNA level positively correlated with pulmonary metastasis, and the relations between TGF β1 and Smads were also found (R2=0.12 and 0.40, respectively).
Conclusions: Our results suggest that TGF β/ Smads promote pulmonary metastasis of HCC.
Figures



Similar articles
-
Induction of tolerogenic dendritic cells by activated TGF-β/Akt/Smad2 signaling in RIG-I-deficient stemness-high human liver cancer cells.BMC Cancer. 2019 May 14;19(1):439. doi: 10.1186/s12885-019-5670-9. BMC Cancer. 2019. PMID: 31088527 Free PMC article.
-
GP73 promotes epithelial-mesenchymal transition and invasion partly by activating TGF-β1/Smad2 signaling in hepatocellular carcinoma.Carcinogenesis. 2018 Jul 3;39(7):900-910. doi: 10.1093/carcin/bgy010. Carcinogenesis. 2018. PMID: 29365054
-
TGF-β1 Promotes Hepatocellular Carcinoma Invasion and Metastasis via ERK Pathway-Mediated FGFR4 Expression.Cell Physiol Biochem. 2018;45(4):1690-1699. doi: 10.1159/000487737. Epub 2018 Feb 22. Cell Physiol Biochem. 2018. PMID: 29490293
-
miR-663a inhibits tumor growth and invasion by regulating TGF-β1 in hepatocellular carcinoma.BMC Cancer. 2018 Nov 28;18(1):1179. doi: 10.1186/s12885-018-5016-z. BMC Cancer. 2018. PMID: 30486878 Free PMC article.
-
Transforming growth factor-β and epithelial-mesenchymal transition are associated with pulmonary metastasis in adenoid cystic carcinoma.Oral Oncol. 2013 Nov;49(11):1051-8. doi: 10.1016/j.oraloncology.2013.07.012. Epub 2013 Aug 17. Oral Oncol. 2013. PMID: 23962790
Cited by
-
Bioinformatics analysis of the gene expression profile of hepatocellular carcinoma: preliminary results.Contemp Oncol (Pozn). 2016;20(1):20-7. doi: 10.5114/wo.2016.58497. Epub 2016 Mar 16. Contemp Oncol (Pozn). 2016. PMID: 27095935 Free PMC article.
-
Gene expression data reveal common pathways that characterize the unifocal nature of ovarian cancer.Am J Obstet Gynecol. 2013 Dec;209(6):576.e1-576.e16. doi: 10.1016/j.ajog.2013.08.004. Epub 2013 Aug 9. Am J Obstet Gynecol. 2013. PMID: 23933223 Free PMC article.
-
Transarterial chemoembolization (TACE) plus percutaneous ethanol injection (PEI) for the treatment of unresectable hepatocellular carcinoma: a meta-analysis of randomized controlled trials.Int J Clin Exp Med. 2015 Jul 15;8(7):10388-400. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 26379829 Free PMC article.
-
Incidence, risk factors, and prognosis in patients with primary hepatocellular carcinoma and lung metastasis: a population-based study.Cancer Manag Res. 2019 Apr 8;11:2759-2768. doi: 10.2147/CMAR.S192896. eCollection 2019. Cancer Manag Res. 2019. PMID: 31040715 Free PMC article.
-
Overexpression of TMEM158 contributes to ovarian carcinogenesis.J Exp Clin Cancer Res. 2015 Aug 4;34(1):75. doi: 10.1186/s13046-015-0193-y. J Exp Clin Cancer Res. 2015. PMID: 26239324 Free PMC article.
References
-
- Ono T, Yamanoi A, Nazmy E, Assal O, Kohno H, Nagasue N. Adjuvant chemotherapy after resection of hepatocellular carcinoma causes deterioration of long-term prognosis in cirrhotic patients: meta analysis of three randomized controlled trials. Cancer. 2001;91:2378–2385. doi: 10.1002/1097-0142(20010615)91:12<2378::AID-CNCR1271>3.0.CO;2-2. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical